Navigation Links
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
Date:11/1/2011

TUESDAY, Nov. 1 (HealthDay News) -- Age in itself should not be a factor in deciding whether blood cancer patients are candidates for stem cell transplantation, according to a new study.

Blood cancers include leukemia, lymphoma and myeloma.

For the study, researchers analyzed long-term outcomes among 372 blood cancer patients aged 60 to 75 who underwent a "mini-transplant," which is a "kinder, gentler" form of allogeneic (cells from another person) stem cell transplantation developed at the Fred Hutchinson Cancer Research Center in Seattle.

The five-year rates of overall survival and disease progression-free survival among the patients were 35 percent and 32 percent, respectively. Comparable survival rates were seen when the patients were divided into three age groups -- 60 to 64, 65 to 69, and 70 to 75 -- suggesting that age plays a limited role in the success of the mini-transplant.

While a survival rate of one-third may seem low, all of the patients would have died within months if they didn't have the transplant, Dr. Mohamed Sorror, an assistant member of the Hutchinson Center's Clinical Research Division, noted in a news release from the Center.

The investigators also found that greater cancer aggressiveness and having a larger number of medical problems not linked to cancer ("comorbidities") were two factors that affected survival, regardless of age.

For example, the five-year survival for patients with less aggressive cancer and fewer comorbidities was 69 percent, compared with 23 percent for patients with more aggressive cancer and a large number of comorbidities, according to the report in the Nov. 2 issue of the Journal of the American Medical Association.

Conventional stem cell transplants are generally not performed on blood cancer patients older than 60 because high doses of total-body radiation and potent chemotherapy are used to prepare patients for transplantation.

However, the mini-transplant relies on the donor's immune cells to kill the cancer, and low-dose radiation and chemotherapy is used to suppress the immune system rather than destroy it.

More information

The U.S. Centers for Disease Control and Prevention has more about blood cancers.

-- Robert Preidt

SOURCE: Fred Hutchinson Cancer Research Center, news release, Nov. 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dementia Rates Escalate as Brain Capacity Diminishes with Age
2. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
3. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
4. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
5. Rate Regulation for Health Insurance: Obama Administration Should Look to CAs Model Law Which Has Saved Drivers $62 Billion Since 1988
6. CareTech Solutions Showcases Web Portal for Hospital Boards and Administrators at HIMSS10
7. National Hispanic Council on Aging Joins the Administration in Mission to Combat Medicare Fraud By Empowering Hispanics
8. Adverse events rate is low when propofol is administered by trained professional
9. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
10. New York State Adopts Universal Provider Datasource to Reduce Administrative Costs for Medicaid
11. The Power of Prayer Deterred Tsunami's Destruction Ministry Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Mini' Stem Cell Transplant May Help Seniors With Blood Cancer
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... 24, 2017 , ... Drs. Nicholas Rallis and Chris Chondrogiannis ... 10 years as clinical instructors for the reputable Full Mouth Rehabilitation continuing education ... program, private practitioners receive cutting-edge clinical training and learn how to perform ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... Global Policy Solutions is vehemently opposed to Donald Trump’s budget, “A New Foundation ... despair that inspires fear, demonizes the poor, marginalizes underserved populations, undermines productivity, and ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... tract in which the endometrial lining of the uterus spreads into the ... Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding may ...
(Date:5/24/2017)... ... ... If you are thinking of a visit to San Francisco , fall is a ... time to visit. , Business Architecture Associates is pleased to offer 5 days of training ... 4-½ day package for individuals, and as 4-½ day corporate package for up to 3 ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... JERUSALEM , May 9, 2017  Oramed ... www.oramed.com ), a clinical-stage pharmaceutical company focused on ... today that the Canadian Intellectual Property Office has ... for Oral Administration of Exenatide". The patent covers ... analog. GLP-1 is an incretin hormone ...
(Date:5/8/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has completed its ... health care service center company based in ... relationship management programs for leading pharmaceutical manufacturers and health ... WRB will join Envoy Health Management, LLC , ... biotech firms, and other service companies. Together, WRB and ...
Breaking Medicine Technology: